Nathan E Reticker-Flynn

8PUBLICATIONS
64CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer cell biologyMolecular targetsPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 10, 2025
Erythropoietin receptor on cDC1s dictates immune tolerance.

Xiangyue Zhang, Christopher S McGinnis, Guotao Yu

|Dec 02, 2025
Reflections on Advances in Cancer Research in 2025.

Elsa Bernard, Isidro Cortés-Ciriano, Federico Gaiti

|Nov 05, 2025
Lymph node environment drives FSP1 targetability in metastasizing melanoma.

Mario Palma, Milena Chaufan, Cort B Breuer

|Aug 13, 2025
Spontaneous and experimental models of lymph node metastasis.

Cort B Breuer, Zhewen Xiong, Alice Wang

|Apr 24, 2025
Tumor-derived erythropoietin acts as an immunosuppressive switch in cancer immunity.

David Kung-Chun Chiu, Xiangyue Zhang, Bowie Yik-Ling Cheng

|Mar 12, 2025
Redirecting immune signaling with cytokine adaptors.

Gita C Abhiraman, Karsten D Householder, Grayson E Rodriguez

Pageof 2